Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kymera Therapeutics, Inc.

KYMR Clue Score27

United States Fiscal year ends December CIK 0001815442 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

Bought (120 mo)

$286.14M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$689.15M

$239.41M on a plan · $128.90M straight out of an exercise

Sold at will

$320.83M

132 of 516 sales

Net

−$403.00M

−$34.69M against sales at will